FDA Drug Application (017566) for BREVICON 21-DAY by ALLERGAN SALES LLC

Back to FDA Applications sponsored by ALLERGAN SALES LLC

Application Number017566
Product Number001
FormTABLET;ORAL-21
Dosage0.035MG;0.5MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBREVICON 21-DAY
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE



Back to FDA Applications sponsored by ALLERGAN SALES LLC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.